Everything there is to know about the hepatocyte.
Hepato. The hepatocyte runs Zone 3 on glycolysis and lipid synthesis, and Zone 1 on oxidative metabolism and gluconeogenesis. Ask me what it does, what goes wrong, what the history says, or what the latest paper found. What are we working on?
The hepatocyte is the workhorse of the liver. It makes up most of the organ's mass and carries out hundreds of distinct biochemical reactions: detoxifying drugs on the smooth endoplasmic reticulum, secreting albumin and clotting factors from the rough ER, storing glycogen, making bile, and running gluconeogenesis or lipogenesis depending on where in the lobule it sits. The cell is polar. Its sinusoidal face takes up nutrients and drugs from portal blood across the space of Disse; its canalicular face secretes bile into canaliculi that drain toward the portal bile ductule.
Source: Boyer JL, Bile formation and secretion. Compr Physiol 2013. PMID 23897680
High-resolution spatial transcriptomics and proteomics map the full zonation gradient in healthy human liver; establishes reference atlas for normal at the molecular level before disease.
PAR3 polarity protein links hepatocyte proliferation to architectural restoration during regeneration; migratory ANXA2+ hepatocytes restore lobular zonation via wound-closure-mediated reorganization.
In vivo CRISPR interference screen in regenerating mouse liver identified NEURL1B as a regulator of mitotic spindle fidelity during hepatocyte division.
AI-enhanced image analysis of H&E and special stains reveals sex-specific differences in MASLD-driven HCC progression and regression.
Steatotic liver creates a pro-metastatic niche via altered zonation, oxygen gradients, lipid metabolism, and immune activity.
AI-assisted scoring of liver biopsies for steatosis, inflammation, ballooning, and fibrosis; reduces interobserver variability on special stains.
Triple stain panel differentiates HCC, hepatic adenoma, and FNH on biopsy. Reticulin is the architectural anchor; GPC3 and GS add immunohistochemical specificity.
Foundational review of trichrome, reticulin, PAS, iron, and copper stains in liver pathology. The primary bench reference.
Non-neoplastic fatty liver can show reticulin loss mimicking HCC; critical caveat for using reticulin alone. Foundational pitfall paper.
Rare HCCs retain reticulin; reticulin alone should not be the sole criterion; glypican-3 and Ki-67 required in equivocal cases.
Reference panel for diagnostic liver pathology: trichrome, reticulin, PAS, PAS-D, iron, rhodanine/orcein; use cases and interpretation.
Head-to-head debate on whether portal inflammation belongs in MASLD activity scoring; NASH CRN system currently does not include portal component.
Updated histologic guidance for MASLD: refined definitions for steatosis, lobular inflammation, hepatocyte ballooning, and portal changes as they relate to fibrosis stage.
Zone 3 is the first site of steatosis and oxidative stress; Zone 1 shows insulin resistance phenotype; fibrosis spreads from Zone 3 outward as zonation breaks down.
Lipid droplet biology as the organizing framework for steatosis: droplet formation, storage, lipolysis, and lipophagy. Histologically visible as macro- and microvesicular change on H&E and PAS.
Semi-quantitative scoring for hepatocellular necrosis, vacuolization, steatosis, fibrosis, and collagen deposition in experimental models; standardizes the histologic language used at the bench.
Morphology of ballooning: swelling, intermediate filament collapse, mitochondrial swelling, membrane blebbing; distinguishes from lipid vacuolization; discusses scoring consistency.
Lipid droplets deform the nucleus and disrupt cytoskeletal networks; mechanobiological basis for how macrovesicular steatosis impairs hepatocyte function beyond simple lipid storage.
Zonation gradients (Wnt, oxygen, bile acids) control hepatocyte gene programs via spatially restricted transcription factor activity; therapeutic window differs by zone.
LSEC-derived FGF1 signals to pericentral hepatocytes via FGFR4 to suppress lipid accumulation; retinoic acid receptor RXRG controls this paracrine axis.
Nr1i3 (CAR nuclear receptor) and Nfix regulate pericentral gene programs; Wnt-driven Nr1i3 expression is the mechanistic link between Wnt gradient and Zone 3 metabolic identity.
Albumin level functions as a paracrine sensor of hepatic mass; signals HSCs to gate regenerative response via an albumin-sensing mechanism.
EGFR-mediated signalling separates hepatocyte proliferation from lipid accumulation after partial hepatectomy; keeping the two programs apart accelerates regeneration and reduces post-operative liver failure.
STING acts as an organelle-stress checkpoint in hepatocytes: sensing mitochondrial and ER damage, it drives fate decisions between survival, pyroptosis, and fibrogenic remodeling. Positions STING as a target beyond antiviral defense.
Partial cellular reprogramming via selective OSK (Oct4/Sox2/Klf4) mRNA LNP delivery to hepatocytes reverses fibrosis markers in mouse model.
Reviews resmetirom (THR-beta agonist), semaglutide (GLP-1), lanifibranor (pan-PPAR), and obeticholic acid (FXR) as zone-aware hepatocyte therapeutics.
Reviews gene therapy and cell therapy approaches targeting hepatocytes; expansion barriers remain a key challenge for clinical-grade cell products.
Organoid-based expansion combined with molecular reprogramming for clinical-grade hepatocyte production; pipeline for cell therapy in liver failure.
Hepatocyte-plus-nonparenchymal-cell microtissues outperform hepatocyte-only systems in functional output (albumin, urea, CYP activity) and survival after transplant into liver failure models.
Controlled oxygenation in perfusion bioreactors rescues CYP450 activity and albumin secretion in iPSC-derived liver tissue; addresses the Zone 3 hypoxia problem in static culture.
Maintained by Hepato. Last updated: 2026-09-14. Every claim has a source; thin claims are marked thin. A paper enters this page only if it is peer-reviewed primary literature (or a review) and its finding is landmark or replicated; preprints, news and single new studies stay in the feed until a second group confirms them.
The hepatocyte has been studied longer than almost any other cell. Here are the moments that defined what we know.
The hepatocyte does everything. That is not an exaggeration.
These are not competing theories. They describe different aspects of the same architecture. Knowing both is non-negotiable.
On H&E you navigate by the classic lobule: find the central vein, find the portal triads. When you interpret injury (who got hurt first?), switch to the acinus model: Zone 1 is the oxygen-rich periportal end, Zone 3 is the oxygen-poor pericentral end.
The hepatocyte is one of the most metabolically active cells in the body. Its ultrastructure reflects that.
The hepatic lobule is a gradient organ. Every hepatocyte's gene program is tuned to its position along the portal-to-central axis.
Molecular basis of zonation: Wnt signaling gradient (highest pericentral, lowest periportal) drives Zone 3 identity. Oxygen gradient (highest periportal) drives Zone 1 oxidative metabolism. Bile acid gradient provides additional positional information. All three are mapped in the 2026 spatial multiomics reference atlas (Ramachandran P, https://pubmed.ncbi.nlm.nih.gov/42481275/).
Regulators: Nr1i3 (nuclear receptor) and Nfix (transcription factor) control hepatocyte maturation and zone identity; CRISPR loss-of-function shifts zone gene programs (thin: single study, mouse; Stephan TL 2026, https://pubmed.ncbi.nlm.nih.gov/41819069/). Pericentral LSEC c-Kit activates FGF1 via RXRG, suppressing hepatocyte lipid accumulation through FGFR4; disrupting this paracrine axis is an early event in Zone 3 steatosis (thin: single study, mouse; Fang Z 2026, https://pubmed.ncbi.nlm.nih.gov/42319926/).
Zone 3 steatosis is the signature of early MASLD: pericentral hepatocytes are more lipogenic and more hypoxia-sensitive. A trichrome shows Zone 3 bridging fibrosis (centrilobular-to-centrilobular) before portal-to-portal bridging appears in many MASLD cases. This is the histologic readout of a molecular gradient being overwhelmed.
Classic hepatocyte lesions and their histological appearance.
The chemistry is what matters here.
The liver is the only solid organ that can regenerate to its original mass after major resection. That capacity lives in the hepatocyte.
Histologic correlate: during active regeneration, reticulin stain shows restoration of one-cell-thick plate architecture as new trabeculae form. Trichrome shows collagen regression if the injury resolves. A regenerating liver that fails to restore reticulin architecture is not healing normally.
Ballooning is not steatosis. A ballooned hepatocyte is dying; a steatotic hepatocyte is storing fat. Getting this right on H&E is what separates a MASLD call from a MASH call.
Scoring systems:
Reversibility: paired biopsies after bariatric surgery show significant reduction in steatosis grade, NAS, and ballooning (thin: single study; Li M 2025, https://pubmed.ncbi.nlm.nih.gov/40844300/). The stain findings are not permanent if the injury resolves.
Mechanical basis: lipid droplets deform the nucleus and disrupt actin cytoskeletal networks before histologic ballooning is visible (thin: single study; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120019/). The functional impairment precedes the stain finding.
The hepatocyte does not work alone. These cells shape its function and its histological appearance.
MASLD reframe: nonparenchymal cells direct hepatocyte function. The fibrosis seen on trichrome reflects HSC activation, not a hepatocyte-intrinsic problem. LSEC zonation signals set the Zone 3 lipogenic program. Hepatocyte pathology must be read in its stromal context (thin: single study; Jaeger JW 2026, https://pubmed.ncbi.nlm.nih.gov/42342151/).
High-resolution spatial transcriptomics and proteomics map the full zonation gradient in healthy human liver; establishes reference atlas for normal at the molecular level before disease.
PAR3 polarity protein links hepatocyte proliferation to architectural restoration during regeneration; migratory ANXA2+ hepatocytes restore lobular zonation via wound-closure-mediated reorganization.
In vivo CRISPR interference screen in regenerating mouse liver identified NEURL1B as a regulator of mitotic spindle fidelity during hepatocyte division.
AI-enhanced image analysis of H&E and special stains reveals sex-specific differences in MASLD-driven HCC progression and regression.
Steatotic liver creates a pro-metastatic niche via altered zonation, oxygen gradients, lipid metabolism, and immune activity.
AI-assisted scoring of liver biopsies for steatosis, inflammation, ballooning, and fibrosis; reduces interobserver variability on special stains.
Triple stain panel differentiates HCC, hepatic adenoma, and FNH on biopsy. Reticulin is the architectural anchor; GPC3 and GS add immunohistochemical specificity.
Foundational review of trichrome, reticulin, PAS, iron, and copper stains in liver pathology. The primary bench reference.